Literature DB >> 2154617

Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA.

R Hamelin1, N Honore, D Sergiescu, B Singh, J Gerfaux, R B Arlinghaus.   

Abstract

Moloney murine sarcoma virus ts110 possesses a thermosensitive splicing defect. By continuously growing nonproducer cells at the nonpermissive temperature, a new class of revertant cells, termed 6m3, that had lost the thermosensitive splicing defect was produced, and six distinct clones were selected. These cell clones were transformed at either permissive or restrictive temperatures. Unlike parental 6m2 cells, which contain two virus-specific RNA species of 4.0 and 3.5 kilobases (kb) at temperatures permissive for transformation, the 3.5-kb RNA was the only virus-specific RNA species detected in 6m3 clones. No new v-mos-containing DNA fragment was observed in Southern blot analysis of these cell clones compared with parental 6m2 cells, indicating that the 3.5-kb RNA was a splicing product rather than a direct transcript. Moreover, these cells expressed P85gag-mos but not P58gag at any temperature. The reversion of the phenotype in 6m3 cell clones appears to be the result of a selective loss of the temperature sensitivity of the splicing reaction, without affecting the thermosensitivity of the protein kinase activity. This change also appears to alter the mechanism regulating the efficiency of the genomic RNA-splicing reaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154617      PMCID: PMC249261          DOI: 10.1128/JVI.64.3.1378-1382.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The isolation and preliminary characterization of temperature-sensitive transformation mutants of Moloney sarcoma virus.

Authors:  D G Blair; M A Hull; E A Finch
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  Electron microscopic analysis of ts1 10 Moloney mouse sarcoma virus, a variant of wild-type virus with two RNAs containing large deletions.

Authors:  R P Junghans; E C Murphy; R B Arlinghaus
Journal:  J Mol Biol       Date:  1982-10-25       Impact factor: 5.469

5.  P85gag-mos encoded by ts110 Moloney murine sarcoma virus: rapid at the restrictive temperature.

Authors:  L H Stanker; G E Gallick; J P Horn; R B Arlinghaus
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

6.  Comparative tryptic peptide analysis of candidate P85gag-mos of ts110 Moloney murine sarcoma virus and P38-P23 mos gene-related proteins of wild-type virus.

Authors:  E C Murphy; R B Arlinghaus
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

7.  A selective temperature-sensitive defect in viral RNA expression in cells infected with a ts transformation mutant of murine sarcoma virus.

Authors:  J P Horn; T G Wood; E C Murphy; D G Blair; R B Arlinghaus
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

8.  S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus.

Authors:  M Nash; N V Brown; J L Wong; R B Arlinghaus; E C Murphy
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity.

Authors:  W S Kloetzer; S A Maxwell; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Characterization of viral RNA in cells transformed by various isolates of Moloney murine sarcoma virus.

Authors:  R Hamelin; J Devaux; N Honoré; M A Auger-Buendia; A Tavitian
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.